Evidence map›Paper›PMID 41030834›Full record

ArticleNanoscale advances2025

Retraction: CTL-doxorubicin (DOX)-gold complex nanoparticles (DOX-AuGCs): from synthesis to enhancement of therapeutic effect on liver cancer model.

Qiqian Liu, Hui Liu, Pasquale Sacco, Nadia Djaker, Marc Lamy de la Chapelle, Eleonora Marsich, Xiaowu Li, Jolanda Spadavecchia

Abstract readRetraction Notice
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanoscale advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Qiqian LiuCNRS, UMR 7244, NBD-CSPBAT, Laboratoire de Chimie, Structures et Propriétés de Biomatériaux et d'Agents Thérapeutiques Université Paris 13 Sorbonne Paris Nord Bobigny France jolanda.spadavecchia@univ-paris13.fr.
Hui LiuDepartment of Hepato-biliary Surgery, Shenzhen University General Hospital, Guangdong Provincial Key Laboratory of Regional Immunity and Diseases, Carson International Cancer Shenzhen 518055 China.
Pasquale SaccoDepartment of Life Sciences, University of Trieste Via L. Giorgieri 5 I-34127 Trieste Italy.
Nadia DjakerCNRS, UMR 7244, NBD-CSPBAT, Laboratoire de Chimie, Structures et Propriétés de Biomatériaux et d'Agents Thérapeutiques Université Paris 13 Sorbonne Paris Nord Bobigny France jolanda.spadavecchia@univ-paris13.fr.
Marc Lamy de la ChapelleDepartment of Medicine, Surgery and Health Sciences, University of Trieste Piazzale Europa 1 I-34127 Trieste Italy.
Eleonora MarsichDepartment of Life Sciences, University of Trieste Via L. Giorgieri 5 I-34127 Trieste Italy.
Xiaowu LiDepartment of Hepato-biliary Surgery, Shenzhen University General Hospital, Guangdong Provincial Key Laboratory of Regional Immunity and Diseases, Carson International Cancer Shenzhen 518055 China.
Jolanda SpadavecchiaCNRS, UMR 7244, NBD-CSPBAT, Laboratoire de Chimie, Structures et Propriétés de Biomatériaux et d'Agents Thérapeutiques Université Paris 13 Sorbonne Paris Nord Bobigny France jolanda.spadavecchia@univ-paris13.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This retracts the article DOI: 10.1039/D0NA00758G.].

Identifiers

PMID41030834
PMCPMC12478200

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.